These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 34761360)

  • 61. A Systematic Literature Review of the Natural History of Respiratory, Swallowing, Feeding, and Speech Functions in Spinal Muscular Atrophy (SMA).
    Martí Y; Aponte Ribero V; Batson S; Mitchell S; Gorni K; Gusset N; Oskoui M; Servais L; Deconinck N; McGrattan KE; Mercuri E; Sutherland CS
    J Neuromuscul Dis; 2024 Jun; ():. PubMed ID: 38943396
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical and Research Readiness for Spinal Muscular Atrophy: The Time Is Now for Knowledge Translation.
    Krosschell KJ; Dunaway Young S; Peterson I; Curry M; Mazzella A; Jarecki J; Cruz R
    Phys Ther; 2022 Oct; 102(10):. PubMed ID: 35904447
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Natural history of Type 1 spinal muscular atrophy: a retrospective, global, multicenter study.
    Cances C; Vlodavets D; Comi GP; Masson R; Mazurkiewicz-Bełdzińska M; Saito K; Zanoteli E; Dodman A; El-Khairi M; Gorni K; Gravestock I; Hoffart J; Scalco RS; Darras BT;
    Orphanet J Rare Dis; 2022 Jul; 17(1):300. PubMed ID: 35906608
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
    Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of the therapeutic efficacy and tolerability of current drug treatments on the clinical outcomes of paediatric spinal muscular atrophy type 1: A systematic review.
    Al-Taie A; Köseoğlu A
    Paediatr Respir Rev; 2023 Dec; 48():65-71. PubMed ID: 37563072
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.
    Clegg A; Bryant J; Nicholson T; McIntyre L; De Broe S; Gerard K; Waugh N
    Health Technol Assess; 2001; 5(1):1-137. PubMed ID: 11262420
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Health State Utility Values in Early-Stage Non-small Cell Lung Cancer: A Systematic Literature Review.
    Jovanoski N; Abogunrin S; Di Maio D; Belleli R; Hudson P; Bhadti S; Jones LG
    Pharmacoecon Open; 2023 Sep; 7(5):723-738. PubMed ID: 37289325
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.
    Hahnen E; Forkert R; Marke C; Rudnik-Schöneborn S; Schönling J; Zerres K; Wirth B
    Hum Mol Genet; 1995 Oct; 4(10):1927-33. PubMed ID: 8595417
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapeutic strategies for spinal muscular atrophy: SMN and beyond.
    Bowerman M; Becker CG; Yáñez-Muñoz RJ; Ning K; Wood MJA; Gillingwater TH; Talbot K;
    Dis Model Mech; 2017 Aug; 10(8):943-954. PubMed ID: 28768735
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Medical rehabilitation of patients with spinal muscular atrophy].
    Ponomarenko GN; Maltsev IS; Koltsov AA; Cherkashina IV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2023; 100(2):5-13. PubMed ID: 37141517
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain.
    López-Bastida J; Peña-Longobardo LM; Aranda-Reneo I; Tizzano E; Sefton M; Oliva-Moreno J
    Orphanet J Rare Dis; 2017 Aug; 12(1):141. PubMed ID: 28821278
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Parents as informal caregivers of children and adolescents with spinal muscular atrophy: a systematic review of quantitative and qualitative data on the psychosocial situation, caregiver burden, and family needs.
    Brandt M; Johannsen L; Inhestern L; Bergelt C
    Orphanet J Rare Dis; 2022 Jul; 17(1):274. PubMed ID: 35854387
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States.
    Lally C; Jones C; Farwell W; Reyna SP; Cook SF; Flanders WD
    Orphanet J Rare Dis; 2017 Nov; 12(1):175. PubMed ID: 29183396
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The economic burden of spinal muscular atrophy.
    Armstrong EP; Malone DC; Yeh WS; Dahl GJ; Lee RL; Sicignano N
    J Med Econ; 2016 Aug; 19(8):822-6. PubMed ID: 27264163
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Spinal muscular atrophy.
    D'Amico A; Mercuri E; Tiziano FD; Bertini E
    Orphanet J Rare Dis; 2011 Nov; 6():71. PubMed ID: 22047105
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A multi-source approach to determine SMA incidence and research ready population.
    Verhaart IEC; Robertson A; Leary R; McMacken G; König K; Kirschner J; Jones CC; Cook SF; Lochmüller H
    J Neurol; 2017 Jul; 264(7):1465-1473. PubMed ID: 28634652
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study.
    Qian Y; McGraw S; Henne J; Jarecki J; Hobby K; Yeh WS
    BMC Neurol; 2015 Oct; 15():217. PubMed ID: 26499462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.